Executive Medical Director, Clinical Development, Pediatric Neurology

Who We Are:

Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. (*in collaboration with AbbVie)

About the Role:

The Executive Medical Director will be primarily responsible for developing and executing the Neurology strategy and driving clinical programs for pediatric neurological diseases like epilepsy and neurodevelopmental disorders. Specific responsibilities will include: being the clinical or program lead for the development of clinical research strategies, clinical development plans, and independent direction of Phase 1-4 clinical studies collaboratively within cross-functional project teams (including clinical operations, preclinical/clinical pharmacology, biometrics, regulatory, drug safety, CMC). Responsible for medical oversight of clinical research studies, providing necessary medical input and decisions (in Sponsor medical monitor role) to the study teams, external partners and clinical sites. Establishes and approves scientific methods for design and implementation of clinical protocols, data collection systems, data analysis and final reports. Partners with Drug Safety Pharmacovigilance on adverse event reporting and safety monitoring committees as required. Coordinates and develops content for reports and submissions to regulatory or other agencies.

Participates in the cross-functional Neurology Therapeutic Area Strategy Group to develop and evolve R&D strategy on new targets, research programs and platform development to support existing and emerging neurology programs, collaborating with other therapeutic areas internally and engaging with external experts as needed to leverage expertise. Collaborates with Research, Preclinical Development, and Experimental Medicine to vet and potentially develop biomarkers necessary for the most effective evaluation of novel molecules. Partners with Business Development in the assessment of external innovation.

_

Your Contributions (include, but are not limited to):

Your Contributions:

• Drive strategic direction for neurology programs during development and overseeing clinical phases. Responsible for the design and implementation of clinical plans, data collection and assessment, and communication of results

• Lead the planning and execution of clinical development projects globally to achieve company objectives in compliance with G